Bayer announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Artificial Intelligence Software for Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Pattern Recognition, which Bayer is currently developing jointly with MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA).
Health at a Glance: Europe 2018, the first step in the State of Health in the EU cycle, is the result of close co-operation between the OECD and the European Commission.The preparation of this publication was led by the OECD, and the Commission provided guidance and technical support throughout the process. This publication would not have been possible without the effort of national data correspondents from the 36 countries who have provided most of the data and the metadata presented in this report, and financial support provided by the European Union.
| Location: | Edinburgh, UK |
| Job Type: | Full-Time |
| Employer: | The University of Edinburgh |
Two pioneering NHS organisations have been recognised at the 2018 HTN Awards for their innovative work using InterSystems technology to help transform care for patients. The judges, who included GPs and clinical commissioning group IT leads, as well as project managers, clinical leads and IT directors from acute trusts and mental health and community providers, selected Coordinate My Care and North Tees and Hartlepool NHS Foundation Trust as winners.
At the Congress of the Radiological Society of North America (RSNA 2018) in Chicago, USA, Siemens Healthineers is presenting AI-Pathway Companion* for the first time. It is a clinical decision support system based on artificial intelligence that supports physicians in making diagnostic and therapeutic decisions along the clinical pathway.
Merck, a leading science and technology company, and software company Palantir Technologies, today announced their intent to form a joint venture under the brand name Syntropy. Syntropy is expected to empower scientists and research centers with a collaborative technology platform to advance cancer research, help drive scientific discovery, and improve human lives.